{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:39:22Z","timestamp":1788406762901,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["\u00daNKP-23-2-III"],"award-info":[{"award-number":["\u00daNKP-23-2-III"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["\u00daNKP-23-3-II"],"award-info":[{"award-number":["\u00daNKP-23-3-II"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018818","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["NKFIH FK 146930"],"award-info":[{"award-number":["NKFIH FK 146930"]}],"id":[{"id":"10.13039\/501100018818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["J\u00e1nos Bolyai Research Scholarship"],"award-info":[{"award-number":["J\u00e1nos Bolyai Research Scholarship"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78415-1","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T03:02:29Z","timestamp":1730775749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Possibilities and limitations of computer assisted chiral HPLC method development for ozanimod on polysaccharide based chiral stationary phases"],"prefix":"10.1038","volume":"14","author":[{"given":"Elek","family":"Ferencz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n-Istv\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Z\u00f6ldhegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Dombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"Dob\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerg\u0151","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"78415_CR1","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1080\/14656566.2018.1540592","volume":"19","author":"L Rasche","year":"2018","unstructured":"Rasche, L. & Paul, F. Ozanimod for the treatment of relapsing remitting multiple sclerosis. Expert Opin. Pharmacother. 19, 2073\u20132086 (2018).","journal-title":"Expert Opin. Pharmacother."},{"key":"78415_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/neurolint12030016","volume":"12","author":"G Lassiter","year":"2020","unstructured":"Lassiter, G. et al. Ozanimod to treat relapsing forms of multiple sclerosis: a comprehensive review of disease, drug efficacy and side effects. Neuro Int. 12, 89\u2013108 (2020).","journal-title":"Neuro Int."},{"key":"78415_CR3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2147\/DDDT.S240861","volume":"15","author":"M Fronza","year":"2021","unstructured":"Fronza, M., Lorefice, L., Frau, J. & Cocco, E. An overview of the efficacy and safety of Ozanimod for the treatment of relapsing multiple sclerosis. Drug Des. Dev. Ther. 15, 1993\u20132004 (2021).","journal-title":"Drug Des. Dev. Ther."},{"key":"78415_CR4","doi-asserted-by":"crossref","unstructured":"Lamb, Y. N.  Ozanimod: First approval. Drugs 80, 841\u2013848 (2020).","DOI":"10.1007\/s40265-020-01319-7"},{"key":"78415_CR5","unstructured":"International Council for Harmonisation. ICH Q3A\u2014Impurities in New Drug Substances (2006)."},{"key":"78415_CR6","unstructured":"International Council for Harmonisation. ICH Q3B\u2014Impurities in New Drug Products (2006)."},{"key":"78415_CR7","first-page":"240","volume":"15","author":"G Hancu","year":"2022","unstructured":"Hancu, G. & Modroiu, A. Chiral switch: between therapeutical benefit and marketing strategy. Pharmaceuticals 15, 240 (2022).","journal-title":"Pharmaceuticals 2022"},{"key":"78415_CR8","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/ejoc.202100058","volume":"2021","author":"C Cianferotti","year":"2021","unstructured":"Cianferotti, C. et al. Enantioselective synthesis of ozanimod, the active pharmaceutical ingredient of a new drug for multiple sclerosis. Eur. J. Org. Chem. 2021, 1924\u20131930 (2021).","journal-title":"Eur. J. Org. Chem."},{"key":"78415_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.chroma.2018.07.033","volume":"1568","author":"S Horv\u00e1th","year":"2018","unstructured":"Horv\u00e1th, S. & N\u00e9meth, G. Hysteresis of retention and enantioselectivity on amylose tris(3,5-dimethylphenylcarbamate) chiral stationary phases in mixtures of 2-propanol and methanol. J. Chromatogr. A 1568, 149\u2013159 (2018).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR10","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1021\/acs.joc.8b03290","volume":"84","author":"F Uthoff","year":"2019","unstructured":"Uthoff, F., L\u00f6we, J., Harms, C., Donsbach, K. & Gr\u00f6ger, H. Chemoenzymatic synthesis of a chiral ozanimod key intermediate starting from naphthalene as cheap petrochemical feedstock. J. Org. Chem. 84, 4856\u20134866 (2019).","journal-title":"J. Org. Chem."},{"key":"78415_CR11","unstructured":"Porcs-Makkay, M. et al. Process for the Production of Ozanimod\u2014Patent No. WO2018\/215807A1 (2018)."},{"key":"78415_CR12","unstructured":"Buchlovic, M., Chalupova, L., Vyklicky, L. & Bartl, J. Process for Preparing Ozanimod\u2014Patent No. US11390593 B2 (2019)."},{"key":"78415_CR13","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/molecules29061346","volume":"29","author":"LA Papp","year":"2024","unstructured":"Papp, L. A., Szab\u00f3, Z. I., Hancu, G., Farcz\u00e1di, L. & Mircia, E. Comprehensive review on chiral stationary phases in single-column simultaneous chiral\u2013achiral HPLC separation methods. Molecules 29, 1346 (2024).","journal-title":"Molecules"},{"key":"78415_CR14","doi-asserted-by":"publisher","first-page":"464367","DOI":"10.1016\/j.chroma.2023.464367","volume":"1708","author":"H Liu","year":"2023","unstructured":"Liu, H., Wu, Z., Chen, J., Wang, J. & Qiu, H. Recent advances in chiral liquid chromatography stationary phases for pharmaceutical analysis. J. Chromatogr. A 1708, 464367 (2023).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR15","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.3390\/molecules28217419","volume":"28","author":"R Dallocchio","year":"2023","unstructured":"Dallocchio, R., Dess\u00ec, A., Sechi, B. & Peluso, P. Molecular dynamics simulations of amylose- and cellulose-based selectors and related enantioseparations in liquid phase chromatography. Molecules 28, 7419 (2023).","journal-title":"Molecules"},{"key":"78415_CR16","doi-asserted-by":"publisher","first-page":"341725","DOI":"10.1016\/j.aca.2023.341725","volume":"1278","author":"B Sechi","year":"2023","unstructured":"Sechi, B. et al. Unravelling dispersion forces in liquid-phase enantioseparation. Part I: impact of ferrocenyl versus phenyl groups. Anal. Chim. Acta 1278, 341725 (2023).","journal-title":"Anal. Chim. Acta"},{"key":"78415_CR17","doi-asserted-by":"publisher","first-page":"461303","DOI":"10.1016\/j.chroma.2020.461303","volume":"1625","author":"P Peluso","year":"2020","unstructured":"Peluso, P. et al. Comparative enantioseparation of chiral 4,4\u2019-bipyridine derivatives on coated and immobilized amylose-based chiral stationary phases. J. Chromatogr. A 1625, 461303 (2020).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR18","doi-asserted-by":"publisher","first-page":"16097","DOI":"10.3390\/ijms242216097","volume":"24","author":"E Ferencz","year":"2023","unstructured":"Ferencz, E. et al. The applicability of chromatographic retention modeling on chiral stationary phases in reverse-phase mode: a case study for ezetimibe and its impurities. Int. J. Mol. Sci. 24, 16097 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"78415_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/chir.20031","volume":"16","author":"EP Sousa","year":"2004","unstructured":"Sousa, E. P. et al. Enantiomeric resolution of kielcorin derivatives by HPLC on polysaccharide stationary phases using multimodal elution. Chirality 16, 279\u2013285 (2004).","journal-title":"Chirality"},{"key":"78415_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jpba.2012.10.015","volume":"74","author":"I Nistor","year":"2013","unstructured":"Nistor, I. et al. Implementation of a design space approach for enantiomeric separations in polar organic solvent chromatography. J. Pharm. Biomed. Anal. 74, 273\u2013283 (2013).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"78415_CR21","doi-asserted-by":"publisher","first-page":"115709","DOI":"10.1016\/j.trac.2019.115709","volume":"122","author":"B Chankvetadze","year":"2020","unstructured":"Chankvetadze, B. Recent trends in preparation, investigation and application of polysaccharide-based chiral stationary phases for separation of enantiomers in high-performance liquid chromatography. Trends Anal. Chem. 122, 115709 (2020).","journal-title":"Trends Anal. Chem."},{"key":"78415_CR22","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1002\/jssc.201500919","volume":"38","author":"I Matarashvili","year":"2015","unstructured":"Matarashvili, I. et al. High-performance liquid chromatographic separations of stereoisomers of chiral basic agrochemicals with polysaccharide-based chiral columns and polar organic mobile phases. J. Sep. Sci. 38, 4173\u20134179 (2015).","journal-title":"J. Sep. Sci."},{"key":"78415_CR23","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/jssc.201701211","volume":"41","author":"ZI Szab\u00f3","year":"2018","unstructured":"Szab\u00f3, Z. I. et al. Chiral separation of lenalidomide by liquid chromatography on polysaccharide-type stationary phases and by capillary electrophoresis using cyclodextrin selectors. J. Sep. Sci. 41, 1414\u20131423 (2018).","journal-title":"J. Sep. Sci."},{"key":"78415_CR24","doi-asserted-by":"publisher","first-page":"464660","DOI":"10.1016\/j.chroma.2024.464660","volume":"1717","author":"G N\u00e9meti","year":"2024","unstructured":"N\u00e9meti, G. et al. High-performance liquid chromatographic enantioseparation of azole analogs of monoterpene lactones and amides focusing on the separation characteristics of polysaccharide-based chiral stationary phases. J. Chromatogr. A 1717, 464660 (2024).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR25","doi-asserted-by":"publisher","first-page":"462741","DOI":"10.1016\/j.chroma.2021.462741","volume":"1662","author":"M Dob\u00f3","year":"2022","unstructured":"Dob\u00f3, M., Foroughbakhshfasaei, M., Horv\u00e1th, P., Szab\u00f3, Z. I. & T\u00f3th, G. Chiral separation of oxazolidinone analogues by liquid chromatography on polysaccharide stationary phases using polar organic mode. J. Chromatogr. A 1662, 462741 (2022).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR26","doi-asserted-by":"publisher","first-page":"464161","DOI":"10.1016\/j.chroma.2023.464161","volume":"1705","author":"S Horv\u00e1th","year":"2023","unstructured":"Horv\u00e1th, S., Nguyen Thuy, H. H., Eke, G. & N\u00e9meth, Z. Exploitation of the enantioselectivity space of coated amylose tris(3,5-dimethylphenylcarbamate) in mixtures of 2-propanol and acetonitrile. J. Chromatogr. A 1705, 464161 (2023).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/scipharm84040671","volume":"84","author":"SB Jadhav","year":"2016","unstructured":"Jadhav, S. B., Mane, R. M., Narayanan, K. L. & Bhosale, P. N. Analytical enantio-separation of linagliptin in linagliptin and metformin HCl dosage forms by applying two-level factorial design. Sci. Pharm. 84, 671\u2013684 (2016).","journal-title":"Sci. Pharm."},{"key":"78415_CR28","doi-asserted-by":"publisher","first-page":"115495","DOI":"10.1016\/j.jpba.2023.115495","volume":"234","author":"LA Papp","year":"2023","unstructured":"Papp, L. A., Hancu, G. & Szab\u00f3, Z. I. Simultaneous determination of enantiomeric and organic impurities of vildagliptin on a cellulose tris(3-chloro-4-methylphenylcarbamate) column under revered-phase conditions. J. Pharm. Biomed. Anal. 234, 115495 (2023).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"78415_CR29","doi-asserted-by":"publisher","first-page":"112851","DOI":"10.1016\/j.jpba.2019.112851","volume":"177","author":"E Ferencz","year":"2020","unstructured":"Ferencz, E. et al. Simultaneous determination of chiral and achiral impurities of ivabradine on a cellulose tris(3-chloro-4-methylphenylcarbamate) chiral column using polar organic mode. J. Pharm. Biomed. Anal. 177, 112851 (2020).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"78415_CR30","doi-asserted-by":"crossref","unstructured":"Wadie, M., Abdel-Moety, E. M., Rezk, M. R. & Tantawy, M. A. Eco-friendly chiral HPLC method for determination of alfuzosin enantiomers and solifenacin in their newly pharmaceutical combination: method optimization via central composite design. Microchem. J. 165 (2021).","DOI":"10.1016\/j.microc.2021.106095"},{"key":"78415_CR31","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3390\/ijms25052697","volume":"25","author":"M Dob\u00f3","year":"2024","unstructured":"Dob\u00f3, M. et al. Simultaneous determination of enantiomeric purity and organic impurities of dexketoprofen using reversed-phase liquid chromatography\u2014enhancing enantioselectivity through hysteretic behavior and temperature-dependent enantiomer elution order reversal on polysaccharide chiral stationary phases. Int. J. Mol. Sci. 25, 2697 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"78415_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpba.2017.06.016","volume":"145","author":"B Bob\u00e1ly","year":"2017","unstructured":"Bob\u00e1ly, B., D\u2019Atri, V., Beck, A., Guillarme, D. & Fekete, S. Analysis of recombinant monoclonal antibodies in hydrophilic interaction chromatography: a generic method development approach. J. Pharm. Biomed. Anal. 145, 24\u201332 (2017).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"78415_CR33","unstructured":"Baczek, T., Kaliszan, R., Claessens, H. & van Straten, M. Computer-assisted optimization of reversed-phase HPLC isocratic separations of neutral compounds. LCGC Europe 2\u20136 (2001)."},{"key":"78415_CR34","unstructured":"Food and Drug Administration. Monography 1220: Analytical procedures life cycle. In United States Pharmacopeia\u2014National Formulary, vol. 1 (2022)."},{"key":"78415_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0021-9673(01)89133-0","volume":"485","author":"LR Snyder","year":"1989","unstructured":"Snyder, L. R., Dolan, J. W. & Lommen, D. C. Drylab\u00ae computer simulation for high-performance liquid chromatographic method development: I. Isocratic elution. J. Chromatogr. A 485, 65\u201389 (1989).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0021-9673(01)89134-2","volume":"485","author":"JW Dolan","year":"1989","unstructured":"Dolan, J. W., Lommen, D. C. & Snyder, L. R. Drylab\u00ae computer simulation for high-performance liquid chromatographic method development: II. Gradient elution. J. Chromatogr. A 485, 91\u2013112 (1989).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0021-9673(94)00877-C","volume":"692","author":"LA Larew","year":"1995","unstructured":"Larew, L. A., Olsen, B. A., Stafford, J. D. & Wilhelm, M. V. Comparison of theory-based and empirical modeling for the prediction of chromatographic behavior in the ion-pairing separation of benzodiazepine-derived pharmaceutical compounds. J. Chromatogr. A 692, 183\u2013193 (1995).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpba.2014.08.035","volume":"102","author":"S Fekete","year":"2015","unstructured":"Fekete, S., Beck, A., Fekete, J. & Guillarme, D. Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, part I: salt gradient approach. J. Pharm. Biomed. Anal. 102, 33\u201344 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"78415_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jpba.2014.09.032","volume":"102","author":"S Fekete","year":"2015","unstructured":"Fekete, S., Beck, A., Fekete, J. & Guillarme, D. Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, part II: pH gradient approach. J. Pharm. Biomed. Anal. 102, 282\u2013289 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"78415_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.chroma.2018.12.020","volume":"1586","author":"V D\u2019Atri","year":"2019","unstructured":"D\u2019Atri, V., Pell, R., Clarke, A., Guillarme, D. & Fekete, S. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates? J. Chromatogr. A 1586, 149\u2013153 (2019).","journal-title":"J. Chromatogr. A"},{"key":"78415_CR41","doi-asserted-by":"publisher","first-page":"2300239","DOI":"10.1002\/sscp.202300239","volume":"7","author":"J Neumann","year":"2024","unstructured":"Neumann, J., Schmidtsdorff, S., Schmidt, A. H. & Parr, M. K. Retention modeling of therapeutic peptides in sub-\/supercritical fluid chromatography. Sep. Sci. Plus 7, 2300239 (2024).","journal-title":"Sep. Sci. Plus"},{"key":"78415_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-4347(96)00366-0","volume":"689","author":"M L\u00e4mmerhofer","year":"1997","unstructured":"L\u00e4mmerhofer, M., Di Eugenio, P., Molnar, I. & Lindner, W. Computerized optimization of the high-performance liquid chromatographic enantioseparation of a mixture of 4-dinitrophenyl amino acids on a quinine carbamate-type chiral stationary phase using drylab. J. Chromatogr. B Biomed. Sci. Appl. 689, 123\u2013135 (1997).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"78415_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpha.2017.03.003","volume":"7","author":"L Zhang","year":"2017","unstructured":"Zhang, L., Hu, Y., Galella, E., Tomasella, F. P. & Fish, W. P. Separation of atropisomers by chiral liquid chromatography and thermodynamic analysis of separation mechanism. J. Pharm. Anal. 7, 156\u2013162 (2017).","journal-title":"J. Pharm. Anal."},{"key":"78415_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/chir.22154","volume":"25","author":"HA Wagdy","year":"2013","unstructured":"Wagdy, H. A., Hanafi, R. S., El-Nashar, R. M. & Aboul-Enein, H. Y. Predictability of enantiomeric chromatographic behavior on various chiral stationary phases using typical reversed phase modeling software. Chirality. 25, 506\u2013513 (2013).","journal-title":"Chirality"},{"key":"78415_CR45","unstructured":"International Council for Harmonisation. ICH Q14\u2014Analytical Procedure Development (2022)."},{"key":"78415_CR46","unstructured":"International Council for Harmonisation. ICH Q9(R1)\u2014Quality Risk Management (2005)."},{"key":"78415_CR47","doi-asserted-by":"crossref","unstructured":"Fekete, S., Moln\u00e1r, I., Rieger, H. J. & Korm\u00e1ny, R. HPLC method development by QbD compatible resolution modeling (DryLab4). In Software-Assisted Method Development in High Performance Liquid Chromatography, World Science (Europe) 11\u201351 (2018).","DOI":"10.1142\/9781786345462_0002"},{"key":"78415_CR48","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s10337-014-2633-9","volume":"77","author":"R Korm\u00e1ny","year":"2014","unstructured":"Korm\u00e1ny, R., Moln\u00e1r, I., Fekete, J., Guillarme, D. & Fekete, S. Robust UHPLC separation method development for multi-API product containing amlodipine and bisoprolol: the impact of column selection. Chromatographia 77, 1119\u20131127 (2014).","journal-title":"Chromatographia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78415-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T07:05:55Z","timestamp":1731049555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78415-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78415"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78415-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4523941\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Imre Moln\u00e1r is the founder, while Arnold Z\u00f6ldhegyi is employed by Moln\u00e1r-Institute for Applied Chromatography, the developer of the DryLab software. All other authors declare no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26757"}}